FMP
Nyxoah S.A.
NYXH
NASDAQ
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
11.29 USD
0.59 (5.23%)
About
ceo
Mr. Olivier Taelman
sector
Healthcare
industry
Medical - Instruments & Supplies
website
https://www.nyxoah.com
exchange
NASDAQ
Description
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
CIK
0001857190
ISIN
BE0974358906
CUSIP
N/A
Address
Rue Edouard Belin 12
Phone
32 1 022 23 55
Country
BE
Employee
146
IPO Date
Apr 28, 2021
Key Executives
